Novo Nordisk's pricing techniques while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of value gouging, pointing out the stark contrast in between U.S. prices and people in Europe and copyright. are scheduled to acquire surgical tr